Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section wording updated to clarify that publications are provided by the person entering information about the study, and the revision number is changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedNotice about government funding and operating status has been removed from the page. All substantive study details (title, eligibility criteria, endpoints, and participation information) remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedThe screenshots show only minor formatting and layout adjustments; there are no changes to core study details like eligibility criteria, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government-operating-status notice and updated version to v3.2.0; - Removed the resource on Mature T-cell and NK-cell non-Hodgkin lymphoma (GRDIC).SummaryDifference3%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated page version from v3.0.1 to v3.0.2, signaling a new release with unspecified fixes or enhancements. Removed the 'Back to Top' link, a minor navigation cleanup.SummaryDifference0.2%

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.